Options on the table for directors looks a little heavy this year. SM is deserving. Not sure about the others at this time. 3.5M on offer. half at 40c, the other half at 50c. Not sure on the re-election yet either. Thoughts from other holders?
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025